A quantitative assay of telomerase activity

被引:18
作者
Gan, YB
Lu, J
Johnson, A
Wientjes, MG
Schuller, DE
Au, JLS
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Ohio State Univ, Arthur James Canc Hosp, Columbus, OH 43210 USA
[3] Ohio State Univ, Richard Solove Res Inst, Columbus, OH 43210 USA
[4] Ohio State Univ, Dept Otolaryngol, Columbus, OH 43210 USA
关键词
telomerase; telomerase assay; TRAP; inhibitor;
D O I
10.1023/A:1011006427733
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose Telomerase is a ribonucleoprotein that extends telomeres at the ends of chromosome. Increased telomerase activity is associated with cellular immortality. The currently available assay for telomerase, ie., telomeric repeat amplification protocol (TRAP), consists of 2 steps: (a) telomerase-mediated extension of an oligonucleotide primer by the enzyme-containing extracts of cells and tissues, and (b) amplification of the telomerase-extended primer products by polymerase chain reaction (PCR) and detection of the PCR products. It is generally accepted that the current TRAP assay lacks quantitative precision. The present study was to develop a quantitative telomerase assay with greater precision and sensitivity. Methods: This new method used the primer extension method as in TRAP; plus the following modifications: (a) used a lysis buffer that yielded complete lysis of nuclei; (b) removal of PCR inhibitors by phenol/chloroform extraction after primer extension; and (c) used primers for the internal standard that were designed to reduce their competition with the telomerase products for PCR. Results. The modified method showed a good correlation (r(2) = 0.99, P < 0.001) between telomerase amount (expressed as total protein in cell lysate) and its activity (expressed as telomerase products). Compared to the conventional TRAP, the new method (a) was more sensitive (average of 5.5-fold in cultured cancer cells and >5.9-fold in patient tumors), (b) had a lower inter- and intra-day variability (>3-fold), and (c) showed a 2 to 4-fold broader range of Linearity in the standard curve. The higher assay sensitivity further enabled the use of a nonradioactive method, i.e., ethidium bromide staining of DNA, to detect the TRAP products, as opposed to the use of radioactive nucleotide and the more labor-intensive autoradiography mandated by the conventional TRAP. Conclusion. We report here a quantitative assay for telomerase activity in cultured human cancer cells and patient tumors.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 15 条
[1]   Anti-apoptotic role of telomerase in pheochromocytoma cells [J].
Fu, WM ;
Begley, JG ;
Killen, MW ;
Mattson, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7264-7271
[2]  
Gelmini S, 1998, CLIN CHEM, V44, P2133
[3]  
Hirose M, 1998, CLIN CHEM, V44, P2446
[4]   Telomerase enzyme activity and RNA expression in Adriamycin-resistant human breast carcinoma MCF-7 cells [J].
Ishikawa, T ;
Kamiyama, M ;
Hisatomi, H ;
Ichikawa, Y ;
Momiyama, N ;
Hamaguchi, Y ;
Hasegawa, S ;
Narita, T ;
Shimada, H .
CANCER LETTERS, 1999, 141 (1-2) :187-194
[5]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[6]   Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) [J].
Kim, NW ;
Wu, F .
NUCLEIC ACIDS RESEARCH, 1997, 25 (13) :2595-2597
[7]  
Melana SM, 1998, CLIN CANCER RES, V4, P693
[8]   Telomere maintenance is dependent on activities required for end repair of double-strand breaks [J].
Nugent, CI ;
Bosco, G ;
Ross, LO ;
Evans, SK ;
Salinger, AP ;
Moore, JK ;
Haber, JE ;
Lundblad, V .
CURRENT BIOLOGY, 1998, 8 (11) :657-660
[9]  
Piatyszek Mieczyslaw A., 1995, Methods in Cell Science, V17, P1, DOI 10.1007/BF00981880
[10]   Simplified method for the telomeric repeat amplification protocol (TRAP) [J].
Sellner, LN ;
Lock, PM ;
Turbett, GR .
BIOTECHNIQUES, 1998, 24 (05) :726-+